Taptap 50mg Tablet ER
Marketer
Superlative Healthcare
Salt Composition
Tapentadol (50mg)
Overview Taptap 50mg Tablet ER
Avelon 50mg Extended-Release Tablets provide relief from moderate to severe acute pain in adults. This medication addresses various pain sources, including headaches, fever, menstrual cramps, dental pain, and the discomfort associated with colds. It's indicated when other pain management options prove ineffective. Dosage and treatment duration for Avelon 50mg ER should strictly follow your physician's instructions. This medication carries a significant risk of dependence. Potential side effects include nausea, somnolence, emesis, and vertigo. Patients with pre-existing cardiac, hepatic, or renal conditions should disclose this information to their doctor. Pregnant women, those planning pregnancy, and breastfeeding mothers must consult their physician before use.
Uses of Taptap 50mg Tablet ER
Significant to intense pain
Major Benefits of Taptap 50mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 50mg extended-release Taptap tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistency is key – take it at the same time each day.
Common Side effects of Taptap 50mg Tablet ER:
- Nausea
- Vomiting
- Dizziness
- Sleepiness
How to use Taptap 50mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 50mg Taptap ER tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistent timing is recommended for optimal results.
How Taptap 50mg Tablet ER works:
Extended-release Taptap 50mg tablets reduce pain sensation by inhibiting nerve signals that communicate pain to the brain.
SAFETY ADVICE
AlcoholUNSAFE
Combining Taptap 50mg Extended-Release Tablets with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Taptap 50mg tablets might pose risks during pregnancy. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Taptap 50mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by side effects of Taptap 50mg Extended-Release Tablets. Refrain from driving if drowsiness, dizziness, blurred vision, or slowed reflexes occur after taking Taptap 50mg Extended-Release Tablets.
KidneyCAUTION
Fifty-milligram extended-release Taptap tablets require careful administration in individuals with impaired renal function. Dosage modification for Taptap 50mg extended-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Taptap 50mg Extended-Release Tablets cautiously; dosage modification may be necessary. Consult your physician. Taptap 50mg Extended-Release Tablets are contraindicated in patients with severe renal impairment.
What if you forget to take Taptap 50mg Tablet ER :
Omit any missed dose of Taptap 50mg Extended-Release Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Taptap 50mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Phenylpropanoid |
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
3,018 People bought this recently